Clinical Trials Browser

Myelodysplastic Syndromes, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Primary Myelofibrosis

NCT02603003 2019-09-20

CTC-TCM-FZ

Phase 1 Completed

218 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplastic Cells, Circulating

NCT03347994 2018-03-06

Minnelide in Adult Patients With Relapsed or Refractory Acute Myeloid Leukemia

Phase 1 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01229618 2015-10-05

Hyperpolarized Pyruvate Injection in Subjects With Prostate Cancer

Phase 1 Completed

31 enrolled

Genitourinary

Prostatic Neoplasms

NCT01163903 2015-07-15

Pantoprazole With Doxorubicin for Advanced Cancer Patients With Extension Cohort of Patients With Solid Tumours

Phase 1 Completed

24 enrolled

Other solid neoplasm

Advanced Solid Tumours

Clinical Trials

Tazemetostat and Palbociclib With CPX-351for R/R AML

Pembrolizumab and Decitabine With or Without Venetoclax in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome That Is Newly-Diagnosed, Recurrent, or Refractory

DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC

Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer

Tegavivint for the Treatment of Relapsed or Refractory Leukemia

Navitoclax in Relapsed or Refractory High-Risk Myelodysplastic Syndrome

Phase I Clinical Study of JS203 in Patients With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

CAR-DC Vaccine and ICIs in Local Advanced/Metastatic Solid Tumors

INTERCEPT-H3

Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.

Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer

Pevonedistat and Decitabine in Treating Patients With High Risk Acute Myeloid Leukemia

Navitoclax, Venetoclax, and Decitabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Previously Treated With Venetoclax

STAT Inhibitor OPB-111077, Decitabine and Venetoclax in Treating Patients With Acute Myeloid Leukemia That Is Refractory, Relapsed or Newly Diagnosed and Ineligible for Intensive Chemotherapy

Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Study on Human Bioequivalence of Triprerelin Acetate for Injection

USmBRT-B

Neoadjuvant Toripalimab and Paclitaxel/Cisplatin on Pathological Response in Oral Squamous Cell Carcinoma Patients

CPX-351 and Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid Leukemia

Combination of CAR-DC Vaccine and ICIs in Malignant Tumors

A Phase I Study of JS108 in Patients With Advanced Solid Tumors

Clinical Study of Safety and Tolerability of Melphalan Hydrochloride for R/R MM

LABC

Oncolytic Virus (OVV-01) Injection in the Treatment of Patients With Advanced Solid Tumors

TIL

DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

Glasdegib-Based Treatment Combinations for the Treatment of Patients With Relapsed Acute Myeloid Leukemia Who Have Undergone Hematopoietic Cell Transplantation

Blinatumomab in Pediatric B-cell Acute Lymphoblastic Leukemia (ALL) With Minimal Residual Disease (MRD)

Study of Oncolytic Virus in Combination With HX-008 and Axitinib in Melanoma Patients With Liver Metastasis

Study of Oncolytic Virus in Combination With HX-008 and Radiotherapy in Melanoma Patients With Liver Metastasis

Sentinel Lymph Node Navigation Surgery Using Near-infrared Imaging in Early Esophageal Cancer

The Combination of Immunotherapy and Stereotactic Ablative Radiotherapy in Oligometastatic Gastrointestinal Cancer

Multiparametric MRI for Prostate Cancer Localization and Characterization Using Hyperpolarized Pyruvate (13C) Injection

Azacitidine and Sonidegib or Decitabine in Treating Patients With Myeloid Malignancies

CTC-TCM-FZ

Minnelide in Adult Patients With Relapsed or Refractory Acute Myeloid Leukemia

Hyperpolarized Pyruvate Injection in Subjects With Prostate Cancer

Pantoprazole With Doxorubicin for Advanced Cancer Patients With Extension Cohort of Patients With Solid Tumours